Literature DB >> 8973526

A sensitive PCR assay system for the quantitation of viral genome equivalents: hepatitis C virus (HCV).

T Hämmerle1, F G Falkner, F Dorner.   

Abstract

A sensitive and reliable quantitative method has been developed for the detection and quantitation of hepatitis C virus (HCV) target sequences. In this procedure, termed "laser induced fluorescence PCR' (LIF-PCR), reverse transcriptase PCR (RT-PCR) is performed and the PCR products are detected and quantified by laser-induced fluorescence. Precise quantitation of the viral target sequences is accomplished by the use of two calibrators that are amplified by the same set of primers as the target template. A high degree of reliability is achieved by co-processing, co-amplification and co-detection of the calibrators, together with the nucleic acid to be determined. Genome equivalents of HCV containing biological samples, including samples from international test panels, were accurately quantitated with this procedure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973526     DOI: 10.1007/bf01718218

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates.

Authors:  S Diviacco; P Norio; L Zentilin; S Menzo; M Clementi; G Biamonti; S Riva; A Falaschi; M Giacca
Journal:  Gene       Date:  1992-12-15       Impact factor: 3.688

2.  Improvement of HCV genome detection with "short" PCR products.

Authors:  J A Garson; C J Ring; P W Tuke
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

Review 3.  Hepatitis C virus six years on.

Authors:  C L van der Poel; H T Cuypers; H W Reesink
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

4.  Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR.

Authors:  J Saldanha; P Minor
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

5.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Reliability of polymerase chain reaction for detection of hepatitis C virus.

Authors:  H L Zaaijer; H T Cuypers; H W Reesink; I N Winkel; G Gerken; P N Lelie
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

7.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.

Authors:  F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

8.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08

Review 9.  Clinical application of reverse transcription-polymerase chain reaction for HIV infection.

Authors:  M Holodniy
Journal:  Clin Lab Med       Date:  1994-06       Impact factor: 1.935

Review 10.  The polymerase chain reaction and hepatitis C virus diagnosis.

Authors:  J A Garson
Journal:  FEMS Microbiol Rev       Date:  1994-07       Impact factor: 16.408

View more
  2 in total

1.  Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection.

Authors:  F Gruber; F G Falkner; F Dorner; T Hämmerle
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

2.  Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  T Vener; M Nygren; A Andersson; M Uhlén; J Albert; J Lundeberg
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.